OnKure Therapeutics (OKUR) Earnings Date & Reports
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
OKUR is expected to report earnings to fall 39.64% to -67 cents per share on August 18
Q2'26
Est.
$-0.67
Q1'26
Missed
by $0.05
Q4'25
Missed
by $0.80
Q3'25
Missed
by $0.78
Q2'25
Missed
by $0.64
The last earnings report on May 05 showed earnings per share of -111 cents, missing the estimate of -105 cents. With 1.65M shares outstanding, the current market capitalization sits at 184.05M.